Survival analysis of acquired immune deficiency syndrome patients with and without hepatitis C virus infection at a reference center for sexually transmitted diseases/acquired immune deficiency syndrome in São Paulo, Brazil

Brazilian Journal of Infectious Diseases

Volumn 18, Issue 2, 2014, Pages 150-157

  Alencar, Wong Kuen ^a   Duarte, Paulo Schiavom ^b   Waldman, Eliseu Alves ^b  

^a Centro de Referencia e Treinamento DST/AIDS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Hepatitis viruses; HIV; Survival analysis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENDER; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; RACE; SEXUALLY TRANSMITTED DISEASE; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; AGE; CAUSE OF DEATH; COHORT ANALYSIS; EXPOSURE; FOLLOW UP; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MIXED INFECTION; MORTALITY; OBSERVATIONAL STUDY; SEX;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HEPATITIS VIRUSES; HIV; SURVIVAL ANALYSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BRAZIL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COINFECTION; EDUCATIONAL STATUS; FEMALE; HEPATITIS C; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

VIRUS RNA;

EID: 84897674125     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.06.006     Document Type: Article

References (45)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) Global report: UNAIDS report on the global AIDS epidemic 2012, Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf [accessed in 16.04.13].
2. Lima V.D., Hogg R.S., Harrigan P.R., et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 2007, 21:685-692.
3. Chequer P., Hearst N., Hudes E.S., et al. Determinants of survival in adult Brazilian AIDS patients, 1982-1989. The Brazilian State AIDS Program Co-Ordinators. AIDS 1992, 6:483-487.
4. Marins J.R., Jamal L.F., Chen S.Y., et al. Dramatic improvement in survival among adult AIDS patients. AIDS 2003, 17:1675-1682.
5. Guibu I.A., Barros M.B.A., Cordeiro M.R.D., Tayra A., Alves M.C.G.P., Pereira G.F.M. Estudo de sobrevida de pacientes de aids no Brasil, 1998 a 1999 - Fase I - Regiões Sul e Sudeste 2008, Centro de Estudos Augusto Leopoldo Ayrosa Galvão, São Paulo, Available from: http://www.sbinfecto.org.br/anexos/11_25_Aids%20-%20Estudo%20de%20sobrevida%20em%20adultos.pdf [accessed 25.06.13].
6. Tancredi M.V. Sobrevida de pacientes com HIV e AIDS nas eras pré e pós terapia antirretroviral de alta potencia 2010, Faculdade de Saúde Pública da Universidade de São Paulo, São Paulo, [tese].
7. Kovari H., Sabin C.A., Ledergerber B., et al. Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study. Clin Infect Dis 2013, 56:870-879.
8. Sulkowski M.S. Current management of hepatitis C virus infection in patients with HIV co-infection. J Infect Dis 2013, 207:S26-S32.
9. Soriano V., Vispo E., Labarga P., Medrano J., Barreiro P. Viral hepatites and HIV co-infection. Antiviral Res 2010, 85:303-315.
10. Ioannou G.N., Bryson C.L., Weiss N.S., Miller R., Scott J.D., Boyko E.J. The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology 2013, 57:249-257.
11. Fundação Sistema Estadual de Análise de Dados Seade. Projeções populacionais. Região Metropolitana de São Paulo 2010, Available from: http://www.seade.gov.br/produtos/projpop/ [accessed 18.04.13].
12. Prefeitura da cidade de São Paulo. Secretaria Municipal da Saúde. Coordenadoria do Programa Municipal de DST/AIDS. Coordenadoria de Vigilância em Saúde. Centro de Controle de Doenças. Boletim Epidemiológico de Aids HIV/DST e Hepatites B e C do Município de São Paulo. 2010;XIV [lei na internet]. Available from: [accessed 15.04.13]. http://www10.prefeitura.sp.gov.br/dstaids/novo_site/images/fotos/Boletim2010.pdf.
13. Gallo R.C., Sarin P.S., Gelmann E.P., et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983, 220:865-867.
14. Barré-Sinoussi F., Chermann J.C., Rey F., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868-871.
15. Clavel F., Guétard D., Brun-Vézinet F., et al. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986, 233:343-346.
16. Griffiths E.C., Pedersen A.B., Fenton A., Petchey O.L. The nature and consequences of coinfection in humans. J Infect 2011, 63:200-206.
17. Branch A.D., Van Natta M.L., Vachon M.L., et al. Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clin Infect Dis 2012, 55:137-144.
18. Sulkowski M.S., Moore R.D., Mehta S.H., Chaisson R.E., Thomas D.L. Hepatitis C and progression of HIV disease. JAMA 2002, 288:199-206.
19. Klein M.B., Rollet K.C., Saeed S., et al. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality. HIV Med 2013, 14:10-20.
20. Than N.N., Sungkanuparph S., Maek-A-Nantawat W., Kaewkungwal J., Pitisuttithum P. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting. Southeast Asian J Trop Med Public Health 2012, 43:646-651.
21. Rezaianzadeh A., Hasanzadeh J., Alipour A., Davarpanah M.A., Rajaeifard A., Tabatabaee S.H. Impact of hepatitis C on survival of HIV-infected individuals in Shiraz; South of Iran. Hepat Mon 2012, 12:106-111.
22. Brasil. Presidência da República. Casa Civil Subchefia para Assuntos Jurídicos. Lei no 9.313, de 13 de novembro de 1996. Dispõe sobre a distribuição gratuita de medicamentos aos portadores do HIV e doentes de AIDS. Diário Oficial da União, 13 de novembro de 1996 [lei na internet]. Available from: [accessed 25.07.13]. http://www.planalto.gov.br/ccivil_03/leis/L9313.htm.
23. Bonacini M., Louie S., Bzowej N., Wohl A.R. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004, 18:2039-2045.
24. Weis N., Lindhardt B.O., Kronborg G., et al. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis 2006, 42:1481-1487.
25. Brasil. Ministério da Saúde Portaria no 1.318/GM, de 23 de julho de 2002 [lei na internet]. Available from: [accessed 25.07.13]. http://dtr2001.saude.gov.br/sas/PORTARIAS/Port2002/Gm/GM-1318.htm.
26. Peters L., Mocroft A., Soriano V., et al. Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression. J Acquir Immune Defic Syndr 2009, 50:457-463.
27. Vogel M., Rockstroh J.K. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS 2009, 4:171-175.
28. Qurishi N., Kreuzberg C., Lüchters G., et al. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003, 362:1708-1713.
29. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients. J Acquir immune Defic Syndr 2007, 46:607-615. Antiretroviral Therapy Cohort Collaboration.
30. Nelson P.K., Mathers B.M., Cowie B., et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011, 378:571-583.
31. Celentano D.D., Vlahov D., Cohn S., Shadle V.M., Obasango O., Moore R.D. Self-reported antiretroviral therapy in injection drug users. JAMA 1998, 280:544-546.
32. Kalichman A. Debate on the paper by David Vlahov & David D Celentano. Cad Saude Publica 2006, 22:727-728.
33. Dimova R.B., Zeremski M., Jacobson I.M., Hagan H., Des Jarlais D.C., Talal A.H. Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clin Infect Dis 2013, 56:806-816.
34. Nikolopoulos G.K., Paraskevis D., Hatzitheodorou E., et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis 2009, 48:1763-1771.
35. Puoti M., Torti C., Bruno R., Filice G., Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006, 44:S65-S70.
36. Torssander J., Erikson R. Stratification and mortality a comparison of education, class, status, and income. Eur Sociol Rev 2010, 26:465-474. Available from: http://esr.oxfordjournals.org/content/26/4/465.abstract [accessed 15.04.13].
37. Darby S.C., Ewart D.W., Giangrande P.L., Spooner R.J., Rizza C.R. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population UK Haemophilia Centre Directors' Organisation. Lancet 1996, 347:1573-1579.
38. Morgan D., Mahe C., Mayanja B., Okongo J.M., Lubega R., Whitworth J.A. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?. AIDS 2002, 16:597-603.
39. Lazarus J.V., Nielsen K.K. HIV and people over 50 years old in Europe. HIV Med 2010, 11:479-481.
40. Holt-Lunstad J., Smith T.B., Layton J.B. Social relationships and mortality risk: a meta-analytic review. PLoS Med 2010, 7:e1000316.
41. Mocroft A., Gill M.J., Davidson W., Phillips A.N. Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?. J Acquir Immune Defic Syndr 2000, 24:475-482.
42. Taylor-Smith K., Tweya H., Harries A., Schoutene E., Jahn A. Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Med J 2010, 22:49-56.
43. Mugavero M.J., Castellano C., Edelman D., Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med 2007, 120:370-373.
44. Arnold M., Hsu L., Pipkin S., McFarland W., Rutherford G.W. Race, place and AIDS: the role of socioeconomic context on racial disparities in treatment and survival in San Francisco. Soc Sci Med 2009, 69:121-128.
45. Woldemichael G., Christiansen D., Thomas S., Benbow N. Demographic characteristics and survival with AIDS: health disparities in Chicago, 1993-2001. Am J Public Health 2009, 99:S118-S123.